Status:
UNKNOWN
Does Meloxicam Provide as Much Pain Relief as Opioids After Shoulder Surgery?
Lead Sponsor:
Rothman Institute Orthopaedics
Conditions:
Shoulder Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The opioid epidemic continues to be a major concern, with orthopedic surgeons being among the top prescribers of opioids. Studies evaluating these practices found that opioids are overprescribed, even...
Eligibility Criteria
Inclusion
- Age ≥ 18
- Scheduled for arthroscopic labrum repair of the shoulder
Exclusion
- History of opioid, acetaminophen, NSAID or local anesthetic allergy or intolerance, or contraindications to these medications.
- Currently on long-term preoperative narcotics
- Scheduled for revision arthroscopic repairs of the shoulder
- Unable/unwilling to consent for enrollment
- Unable to complete postoperative surveys
- History of chronic pain syndromes (fibromyalgia, chronic diffuse MSK pain, etc)
- Patients under the age of 18
- Pregnant or breastfeeding women
- Scheduled for concurrent procedures
Key Trial Info
Start Date :
January 25 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 25 2022
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT04725357
Start Date
January 25 2021
End Date
January 25 2022
Last Update
January 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, United States, 19107